US › Healthcare

Jupiter Neurosciences, Inc. Common Stock (JUNS)

US · Healthcare · Biotechnology

$2.20+3.29%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$24,245

Net profit

$-2.3M

EPS

$-5.06

Net margin

-9,380.9%

Key statistics

Market cap

$2.8M

Forward P/E

28.7

P/B

44.71

Book value

$-0.55

EPS (TTM)

$-18.94

52-week high

$103.50

52-week low

$2.01

50-day MA

$2.97

200-day MA

$19.61

Analyst view

with an average price target of $30.00.

Shareholding

Insiders

29.96%

Institutions

2.25%

Largest institutional holders

Fund	Stake
Virtu Financial LLC	0.23%
Geode Capital Management, LLC	0.16%
Vanguard Capital Management, LLC	0.13%
Vanguard Fiduciary Trust Co	0.09%
Northern Trust Corp	0.03%
Vestor Capital Partners	0.00%
Midfirst Bank	0.00%
Citigroup Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Jupiter Neurosciences, Inc. Common Stock — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.